- Home
- RELL vs ABEO Comparison
RELL vs ABEO Comparison
Compare RELL & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RELL | ABEO |
|---|---|---|
| Founded | 1947 | 1974 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electronic Components | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 248.1M | 282.5M |
| IPO Year | 2004 | 2005 |
Fundamental Metrics
Financial Performance| Metric | RELL | ABEO |
|---|---|---|
| Price | $19.92 | $4.47 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | ★ $25.50 | $18.88 |
| AVG Volume (30 Days) | 342.9K | ★ 1.0M |
| Earning Date | 10-07-2026 | 11-11-2026 |
| Dividend Yield | ★ 1.15% | N/A |
| EPS Growth | N/A | ★ 165.16 |
| EPS | ★ N/A | N/A |
| Revenue | ★ $228,564,000.00 | $2,998,000.00 |
| Revenue This Year | $12.68 | $804.33 |
| Revenue Next Year | $9.21 | $119.68 |
| P/E Ratio | $230.96 | ★ N/A |
| Revenue Growth | 9.41 | ★ 258.18 |
| 52 Week Low | $9.37 | $4.00 |
| 52 Week High | $23.15 | $7.65 |
Technical Indicators
Market Signals| Indicator | RELL | ABEO |
|---|---|---|
| Relative Strength Index (RSI) | 54.39 | 38.54 |
| Support Level | $15.83 | $4.27 |
| Resistance Level | $21.62 | $5.91 |
| Average True Range (ATR) | 1.15 | 0.22 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 66.15 | 30.00 |
Price Performance
Historical ComparisonAbout RELL Richardson Electronics Ltd.
Richardson Electronics Ltd is a world-wide manufacturer of engineered solutions, green energy products, power grid and microwave tubes, and related consumables; power conversion and RF and microwave components including green energy solutions; tubes for diagnostic imaging equipment; and customized display solutions. It serve customers in alternative energy, healthcare, aviation, broadcast, communications, industrial, marine, medical, military, scientific, and semiconductor markets. Its products and services include design-in support, systems integration, prototype design and manufacturing, testing, logistics, etc. Its segments are Power and Microwave Technologies (PMT), Green Energy Solutions (GES), and Canvys. Majority of Sales is from PMT. Majority of sales is from North America.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a commercial-stage biopharmaceutical company. The company is focused on developing cell and gene therapies for life-threatening diseases. The company's ZEVASKYN (prademagene zamikeracel) is an autologous cell-based gene therapy for the treatment of wounds in adults and pediatric patients with recessive dystrophic epidermolysis bullosa (RDEB). The company's development portfolio includes adeno-associated virus (AAV)-based gene therapies for ophthalmic diseases with high unmet medical need.